These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 12240839

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H.
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V, Ingsathit A, Jirasiritham S.
    Transplant Proc; 2009 Mar; 41(1):213-5. PubMed ID: 19249516
    [Abstract] [Full Text] [Related]

  • 31. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M, Sharma A, Das A, Chawla Y.
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [Abstract] [Full Text] [Related]

  • 35. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
    Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F.
    Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400
    [Abstract] [Full Text] [Related]

  • 36. Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D.
    Taniguchi M, Shakil AO, Vargas HE, Laskus T, Demetris AJ, Gayowski T, Dodson SF, Fung JJ, Rakela J.
    Liver Transpl; 2000 Jan; 6(1):92-6. PubMed ID: 10648584
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.
    Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U.
    Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076
    [Abstract] [Full Text] [Related]

  • 39. Occult hepatitis B in renal transplant patients.
    Peres AA, Dias EA, Chesky M, Alvares-da-Silva MR, Jobim LF, Gonçalves LF, Manfro RC.
    Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.